By George Paraskevakos, MBA, IPA Executive Director
As an observer of the dietary supplement industry for close to 20 years, it always felt we are shifting to accommodate “Winds of Change". There are always new concepts and ingredients which capture our attention even if it is for a small moment in...
The Early Bird discount for the 2023 IPA World Congress + Probiota will expire on Friday, 25th November, so book now to ensure your spot at the leading event for the global microbiome modulation community.
Growth in the probiotic supplements market has not returned to pre-pandemic levels, and interest in the beneficial microorganisms continues to gather pace, says the executive director of the International Probiotics Association.
Consumers are increasingly aware of CFU on probiotic labels, but we may see more products using AFUs, a measure obtained using flow cytometry that is a fast, more accurate, and potentially cost-effective to traditional plate counts.
Gut-brain axis (GBX)-focused probiotic supplements have tripled to 200+ offerings since 2019, as promising science and self-medicating consumers seek solutions to a global mental health crisis afflicting a billion people, according to Lumina Intelligence.
I recently came across, what was dubbed a space movie and recalled one of the reviews which stood out the most; “The Martian is a film about human error, the will to survive, and the responsibility that we have as human beings, not just to the work that...
There are over 1,600 human clinical trials on probiotics listed in ClinicalTrials.gov and the WHO’s trial database, according to a new analysis that seeks to address the misconception that there is no human data around probiotics.
As growth in probiotics continues to accelerate, the International Probiotics Association is ramping up its regulatory outreach efforts and working on ultimately producing a comprehensive quality guidebook for the probiotic industry, says IPA’s executive...
A combination of four probiotic strains may shorten the duration of an infection with Clostridium difficile, says a new study that supports the role of probiotics to counter the most common cause of hospital-acquired infections.